Nrf2 activators as attractive therapeutics for diabetic nephropathy

Diabetes. 2011 Nov;60(11):2683-4. doi: 10.2337/db11-1072.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acrolein / analogs & derivatives*
  • Acrolein / therapeutic use
  • Animals
  • Diabetic Nephropathies / prevention & control*
  • Humans
  • Isothiocyanates
  • NF-E2-Related Factor 2 / agonists*
  • Sulfoxides
  • Thiocyanates / therapeutic use*

Substances

  • Isothiocyanates
  • NF-E2-Related Factor 2
  • Sulfoxides
  • Thiocyanates
  • Acrolein
  • sulforaphane
  • cinnamaldehyde